Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression
- 1 August 2011
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 82 (3), 216-226
- https://doi.org/10.1016/j.bcp.2011.04.011
Abstract
No abstract availableKeywords
Funding Information
- National Nuclear R&D Program of the Ministry Sciences and Technology (2011-0009503), Republic of Korea
This publication has 24 references indexed in Scilit:
- Activating transcription factor 4 and CCAAT/enhancer-binding protein-β negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stressFree Radical Biology & Medicine, 2009
- Targeted Therapy for the Treatment of Advanced Non-small Cell Lung CancerChest, 2005
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complexGenes & Development, 2004
- Kinase Inhibition with BAY 43–9006 in Renal Cell CarcinomaClinical Cancer Research, 2004
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in ApoptosisMolecular and Cellular Biology, 2002
- A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and AktProceedings of the National Academy of Sciences, 2000
- RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1Proceedings of the National Academy of Sciences, 1998
- RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.Proceedings of the National Academy of Sciences, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994